ArticleVaccines2023
An Oral Galectin Inhibitor in COVID-19-A Phase II Randomized Controlled Trial.
Alben Sigamani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleVaccines2023
Alben Sigamani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.